Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics
CONCLUSIONS: Biologic use before PCP onset did not increase the severity and mortality of PCP compared to non-biologics use in patients with RA.PMID:38452442 | DOI:10.1016/j.resinv.2024.02.015
Source: Respiratory Care - Category: Respiratory Medicine Authors: Shin-Ichiro Ohmura Hiroki Matsui Toshiaki Miyamoto Daisuke Shichi Takayuki Masui Katsutoshi Ichijo Yuya Homma Haruka Fujioka Tatsuya Nagai Kei Nakashima Source Type: research
More News: Arthritis | Intensive Care | Pneumonia | Prednisolone | Respiratory Medicine | Rheumatoid Arthritis | Rheumatology | Study